Author:
Leich E, ,Hoster E,Wartenberg M,Unterhalt M,Siebert R,Koch K,Klapper W,Engelhard M,Puppe B,Horn H,Staiger A M,Stuhlmann-Laeisz C,Bernd H W,Feller A C,Hummel M,Lenze D,Stein H,Hartmann S,Hansmann M L,Möller P,Hiddemann W,Dreyling M,Ott G,Rosenwald A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference30 articles.
1. Harris NL, Swerdlow SH, Jaffe ES, Ott G. Follicular lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H et al. (eds). WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC: Lyon, France, 2008, pp 220–226.
2. Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP . New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447–8452.
3. Kridel R, Sehn LH, Gascoyne RD . Pathogenesis of follicular lymphoma. J Clin Invest 2012; 122: 3424–3431.
4. Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 2009; 114: 826–834.
5. Roulland S, Kelly RS, Morgado E, Sungalee S, Solal-Celigny P, Colombat P et al. t(14;18) Translocation: a predictive blood biomarker for follicular lymphoma. J Clin Oncol 2014; 32: 1347–1355.